Please use this identifier to cite or link to this item:
|Title:||Feasibility of a laboratory setup for bioavailability and bioequivalence studies|
Azzopardi, Lilian M.
|Keywords:||Drugs -- Therapeutic equivalency -- Research|
Drugs -- Therapeutic equivalency -- Malta
Bioavailability -- Research
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Farrugia, N., Serracino-Inglott, A., & Azzopardi, L. M. (2014, March). Feasibility of a laboratory setup for bioavailability and bioequivalence studies. Poster session presented at the World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbon, Portugal.|
|Abstract:||A poster presentation regarding the feasibility of a laboratory setup for bioavailability and bioequivalence studies. Introduction: The Maltese islands are a hub for various world class pharmaceutical companies specializing in the production of generic drugs. Since bioequivalence to the originator product is the determining factor in the production of generics, the necessity for and the feasibility of setting up a local independent facility dedicated to carrying out bioequivalence testing was investigated. Aims: • To create a lab setup, operating under GLP, equipped to carry out bioequivalence studies • To validate relevant methods using sample APIs • To determine the feasibility of the lab, servicing the local industry.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Feasibility_of_a_laboratory_setup_for_bioavailability_and_bioequivalence_studies_2014.pdf||591.83 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.